2008 |
|
| 17 March | New executives appointed in senior, global roles QuoNova accelerating compound development towards commercialization ... QuoNova LLC has appointed three new senior executives in global roles to support its next phase of growth. More >> |
| 07 February | QSB anti-virulence platform inhibits biofilm formation by Staphylococcus aureus MRSA and Candida sp. QuoNova LLC has generated preliminary in-vitro data indicating high efficacy of selected Quorum Sensing Blockers ("QSB") in inhibiting biofilm ... More >> |
2007 |
|
| 11 December | Quorum sensing blocker technology milestone in the development of a new treatment for wound-related bacterial infections QuoNova LLC has achieved an important, early-stage milestone in the development of a new treatment for wound-related bacterial infections... More >> |
2006 |
|
| 28 December | XL TechGroup creates its fifth company, QuoNova XL TechGroup, Inc. is pleased to announce the creation of QuoNova LLC, the fifth company to reach the development stage of XL TechGroup's proven methodology for value creation. More >> |
QuoNova™ LLC was established in December 2006 by XL Tech Group, Inc.